Hydrochloric Acid → 5-(2-Tert-butylpyridin-4-yl)-4-methylthiazol-2-amine

HRID 874062ノート

反応式

HRID 874062 の反応式
[C:1]([C:5]1[CH:10]=[C:9]([C:11]2[S:15][C:14]([NH:16]C(=O)C)=[N:13][C:12]=2[CH3:20])[CH:8]=[CH:7][N:6]=1)([CH3:4])([CH3:3])[CH3:2].Cl>CCO>[C:1]([C:5]1[CH:10]=[C:9]([C:11]2[S:15][C:14]([NH2:16])=[N:13][C:12]=2[CH3:20])[CH:8]=[CH:7][N:6]=1)([CH3:4])([CH3:3])[CH3:2]

参加物

4

反応物 2

HCID 313Hydrochloric AcidHCID 59293656N-[5-(2-tert-butyl-pyridin-4-yl)-4-methyl-thiazol-2-yl]acetamide

生成物 1

HCID 574170735-(2-Tert-butylpyridin-4-yl)-4-methylthiazol-2-amine収率 69.9%

試薬・触媒・溶媒 1

HCID 702Ethanol溶媒

実験手順

A mixture of N-[5-(2-tert-butyl-pyridin-4-yl)-4-methyl-thiazol-2-yl]-acetamide (Step 1.3) (2 g, 7 mmol), a 6N aqueous solution of HCl (10 mL) and EtOH (50 mL) is stirred for 2 h at 85° C., allowed to cool, quenched by addition of a saturated solution of NaHCO3 and extracted with DCM/MeOH (9:1, v/v). The organic phase is washed with a saturated solution of NaHCO3, dried (Na2SO4), filtered and concentrated. The residue is purified by silica gel column chromatography (DCM/MeOH, 1:0→96:4) to afford 1.21 g of the title compound as a yellow solid: ESI-MS: 248.1 [M+H]+; TLC: Rf=0.36 (DCM/MeOH, 9:1).

後処理

  1. temperatureto cool
  2. customquenched by addition of a saturated solution of NaHCO3
  3. extractionextracted with DCM/MeOH (9:1
  4. washThe organic phase is washed with a saturated solution of NaHCO3
  5. dry with materialdried (Na2SO4)
  6. filtrationfiltered
  7. concentrationconcentrated
  8. customThe residue is purified by silica gel column chromatography (DCM/MeOH, 1:0→96:4)

出典と根拠

ORDレコード
ord-b385adae16e541d9ba33b85f8abdd3d1
出典データセット
uspto-grants-2015_03
特許番号
US08980259B2

反応ノート

読み込み中…